Charles Kummeth Joins NuSil Technology Board of Directors

Share Article

Charles brings a wealth of global business and life sciences experience that will be invaluable as NuSil continues to implement their strategy of accelerated growth and expansion in the life sciences and advanced engineering markets.

NuSil Technology LLC (http://www.nusil.com), the global leader in high performance, high purity silicones for the life sciences and advanced engineering markets, announces the appointment of Charles Kummeth to its board of directors. Mr. Kummeth is the President and Chief Executive Officer of Bio-Techne, a global life sciences company providing bioactive tools and resources for the research and clinical diagnostic communities.

“I am delighted that Chuck has agreed to join the NuSil Board,” said Ernest Waaser, Chief Executive Officer of NuSil Technology. “He brings over 30 years of global business and life sciences experience that will be invaluable to us as we continue to implement our strategy of accelerated growth and expansion in the life sciences and advanced engineering markets.”

Prior to Bio-Techne, Mr. Kummeth served as President of Mass Spectrometry and Chromatography at Thermo Fisher Scientific Inc. and was also President of the Laboratory Consumables Division. Prior to joining Thermo Fisher, Mr. Kummeth spent 24 years at 3M Corporation, most recently as Vice President of the company’s Medical Division.

Mr. Kummeth received a Master of Science in Computer Science from the University of St. Thomas and a Master of Business Administration from the Carlson School of Business at the University of Minnesota. He is a graduate of the University of North Dakota, where he received a Bachelor of Science in Electrical Engineering.

“We are thrilled to have an executive of Chuck’s caliber joining the NuSil Board,” said Matt Holt, a member of the Board of Directors and Managing Director of New Mountain Capital, NuSil’s majority shareholder. “He has a tremendous track record of building value in high growth, differentiated life sciences businesses and we look forward to his insights and guidance as we continue to build on the outstanding growth momentum that has been established at NuSil.”

“It is an honor to join the Board of a high growth technology company that provides solutions to some of the most demanding applications in the world,” said Mr. Kummeth. “NuSil is a leader in silicone materials science with a unique set of capabilities and technologies, perfectly positioned for the many challenging medical applications of the future. I look forward to working with the Board and the management team to continue to grow and expand an already exceptional company.”

For more information, please contact NuSil at +1 805-684-8780, or visit http://www.nusil.com.

###

About NuSil Technology LLC
NuSil Technology, the global leader in medical and space-grade silicones, draws on over three decades of manufacturing expertise and innovation to develop products used in the most extreme environments – from deep inside the human body to the harsh conditions of outer space. The result of a deep commitment to engaging our customers as collaborators, our best-in-class product lines are the choice for innovators in drug delivery, medical implants, general healthcare, skin care and advanced engineering.

NuSil operates state-of-the-art laboratories and manufacturing facilities in North America and provides on-site, in-person application engineering support worldwide. For more information about how we're transforming the science of silicone into the Chemistry of CareTM, visit us at http://www.nusil.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Stephenb@nusil.com
Visit website